|
CLPX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.038820E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.105400E-01 |
| Normal-vs-Stage2 |
3.919600E-01 |
| Normal-vs-Stage3 |
1.242770E-01 |
| Normal-vs-Stage4 |
1.949810E-02 |
| Stage1-vs-Stage2 |
9.903800E-01 |
| Stage1-vs-Stage3 |
5.144200E-01 |
| Stage1-vs-Stage4 |
1.043230E-01 |
| Stage2-vs-Stage3 |
6.664400E-01 |
| Stage2-vs-Stage4 |
2.728800E-01 |
| Stage3-vs-Stage4 |
3.919800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.640850E-01 |
| Normal-vs-AfricanAmerican |
7.053800E-01 |
| Normal-vs-Asian |
1.697840E-01 |
| Caucasian-vs-AfricanAmerican |
1.779010E-01 |
| Caucasian-vs-Asian |
7.874200E-01 |
| AfricanAmerican-vs-Asian |
1.706990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.115010E-01 |
| Normal-vs-Female |
1.426190E-01 |
| Male-vs-Female |
6.157000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.184000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.241790E-01 |
| Normal-vs-Age(61-80Yrs) |
5.564000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.300750E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.998000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.785360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.627000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.118200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.004400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.335400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.462800E-01 |
| Classical-VS-Follicular |
5.245800E-04 |
| Classical-VS-Other |
2.054400E-01 |
| Classical-VS-Normal |
7.122000E-01 |
| Tall-VS-Follicular |
2.992600E-01 |
| Tall-VS-Other |
4.459400E-01 |
| Tall-VS-Normal |
1.501450E-01 |
| Follicular-VS-Other |
9.242400E-01 |
| Follicular-VS-Normal |
5.300900E-03 |
| Other-VS-Normal |
1.222780E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.888300E-02 |
| Normal-vs-N1 |
1.225910E-02 |
| N0-vs-N1 |
2.934600E-01 |
|
|
